文献速递痛风与晶体性关节病

痛风患者的共病聚类:一项链接病历审查的观察性队列研究

Comorbidity clusters in people with gout: an observational cohort study with linked medical record review.
PubMed 文献 · Rheumatology (Oxford) · 2018-01-01

该研究基于英国初级保健前瞻性观察队列的基线数据,对1079例痛风患者进行横断面分析,通过因子分析和层次聚类分析识别出4个共病聚类(C1-C4)。C1组年龄最大、痛风发作最频繁且97%有慢性肾病;C2组为孤立性痛风但饮酒更频繁;C3组高血压、糖尿病、高脂血症、冠心病和/或慢性肾病常见且降尿酸治疗处方更多;C4组全部有高血压且更易肥胖。作者认为应根据聚类和共病情况考虑个体化治疗。

要点

  • 1079例痛风患者中识别出4个共病聚类,C1占18%、C2占36%、C3占27%、C4占18%。
  • C1组年龄最大、痛风发作最频繁,97%有慢性肾病。
  • C2组为孤立性痛风但饮酒更频繁;C4组全部有高血压且更易肥胖。

核心结论

  • 识别出4个不同的共病聚类,多共病患者更可能接受别嘌醇治疗,作者认为应考虑根据聚类和共病情况个体化治疗。

研究设计与样本

  • 横断面研究,使用基于初级保健的前瞻性观察队列的基线数据,纳入年龄⩾18岁的痛风患者,通过初级保健病历识别,共1079例,平均(标准差)年龄65.5岁(12.5),909例(84%)为男性。
  • 采用因子分析获得共病变量的不同聚类,共病变量包括肥胖、高血压、糖尿病、高脂血症、冠心病、心力衰竭、慢性肾病和癌症;并对患者观察值进行层次聚类分析以识别基于共病组合的同质子群。

主要发现

  • 聚类C1(n=197,18%)为年龄最大组且痛风发作最频繁,97%有慢性肾病。
  • 聚类C2(n=393,36%)为孤立性痛风,共病少但饮酒更频繁。
  • 聚类C3(n=296,27%)中高血压、糖尿病、高脂血症、冠心病和/或慢性肾病常见,降尿酸治疗处方比其他聚类更频繁。
  • 聚类C4(n=193,18%)所有患者均有高血压,且比其他聚类更可能肥胖。

临床怎么用

  • 作者认为应考虑根据聚类和共病情况个体化治疗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate how comorbid conditions cluster in patients with gout in a UK primary care population. METHODS: A cross-sectional study was performed using baseline data from a primary-care-based prospective observational cohort of people aged ⩾18 years with gout. Participants with gout were identified through primary care medical records. Factor analysis was performed to obtain distinct clusters of comorbidity variables including obesity, hypertension, diabetes mellitus, hyperlipidaemia, coronary heart disease, heart failure, chronic kidney disease (CKD) and cancer. Hierarchical cluster analysis of patient observations was also performed to identify homogenous subgroups of patients based on combinations of their comorbidities. RESULTS: Four distinct comorbidity clusters (C1-C4) were identified in 1079 participants [mean (s.d.) age 65.5 years (12.5); 909 (84%) male]. Cluster C1 (n = 197, 18%) was the oldest group and had the most frequent attacks of gout; 97% had CKD. Participants in C2 (n = 393, 36%) had isolated gout with few comorbidities but drank alcohol more frequently. In cluster C3 (n = 296, 27%), hypertension, diabetes mellitus, hyperlipidaemia, coronary heart disease and/or CKD were prevalent, and urate-lowering therapy was prescribed more frequently than in other clusters. All patients in C4 (193, 18%) had hypertension and were more likely to be obese than other clusters. CONCLUSION: Four distinct comorbidity clusters were identified. People with multiple comorbidities were more likely to receive allopurinol. Tailoring of treatments depending on cluster and comorbidities should be considered.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Bevis M, Blagojevic-Bucknall M, Mallen C, et al. Comorbidity clusters in people with gout: an observational cohort study with linked medical record review. Rheumatology (Oxford). 2018. PMID: 29672754. doi:10.1093/rheumatology/key096

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。